home *** CD-ROM | disk | FTP | other *** search
- HEALTH, Page 65Silicone Blues
-
-
- Dow Corning tries to shore up its sagging image
-
-
- It was a textbook case of crisis mismanagement. Hit by
- hundreds of lawsuits and a federal probe into the safety of its
- silicone breast implants, Dow Corning spent much of the past
- year hunkered down in a defensive crouch -- stalling
- investigators, sitting on evidence and minimizing the complaints
- of women who said the devices caused them pain, disfigurement
- and serious autoimmune disorders. By the time the Food and Drug
- Administration called for a ban on the implants last month, Dow
- Corning's health and safety problem mushroomed into a public
- relations disaster.
-
- Now, belatedly, the company that produced most of the 1
- million to 2 million implants for American women is attempting
- to make amends. Having hired former Attorney General Griffin
- Bell to review its past handling of the safety issue, it moved
- quickly last week to put forward a new, more open corporate
- face, replacing intransigent chief executives and releasing
- hundreds of documents that it had tried for months to keep out
- of the public eye.
-
- To a large degree, Dow made a virtue of necessity. The FDA
- had threatened to make the documents public anyway, and some of
- the most damaging information had already leaked to the press.
- Still, the firm's moves last week reflected a new public
- relations savvy, if not a heightened corporate conscience. First
- it stopped the hemorrhaging of bad news by putting out all the
- documents at once. A few hours later, it announced the bold
- management changes.
-
- Dow Corning's new chairman, Keith McKennon, a veteran of
- Dow Chemical's Agent Orange and dioxin crises, promised to
- cooperate with the FDA and hinted that the company might even
- help women who wanted their implants removed and could not
- afford the surgery. But Dow Corning's problems are not over.
- Last week a congressional committee asked for a criminal
- investigation into the firm's handling of implants. Among the
- evidence: a 1980 memo from a Dow Corning salesman complaining
- that the company's decision to put "a questionable lot of
- mammaries on the market . . . has to rank right up there with
- the Pinto gas tank."
-
-
-
-
-
-
-
-
-